Login / Signup
Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes.
Cheng-Yuan Peng
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
type diabetes
skeletal muscle
replacement therapy